LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 49 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $396,113 | +1.8% | 400,000 | 0.0% | 0.06% | +3.8% |
Q4 2022 | $389,250 | +0.6% | 400,000 | 0.0% | 0.05% | -8.6% |
Q3 2022 | $387,000 | +1.0% | 400,000 | 0.0% | 0.06% | +3.6% |
Q2 2022 | $383,000 | -43.7% | 400,000 | -42.9% | 0.06% | -33.3% |
Q1 2022 | $680,000 | -2.4% | 700,000 | 0.0% | 0.08% | +3.7% |
Q4 2021 | $697,000 | -0.6% | 700,000 | 0.0% | 0.08% | -10.0% |
Q3 2021 | $701,000 | +1.3% | 700,000 | 0.0% | 0.09% | +3.4% |
Q2 2021 | $692,000 | -4.6% | 700,000 | 0.0% | 0.09% | -6.5% |
Q1 2021 | $725,000 | -14.4% | 700,000 | -22.2% | 0.09% | -11.4% |
Q4 2020 | $847,000 | +4.3% | 900,000 | 0.0% | 0.10% | -13.9% |
Q3 2020 | $812,000 | +2.9% | 900,000 | 0.0% | 0.12% | -10.9% |
Q2 2020 | $789,000 | -4.5% | 900,000 | -10.0% | 0.14% | -12.2% |
Q1 2020 | $826,000 | -4.3% | 1,000,000 | 0.0% | 0.16% | +28.9% |
Q4 2019 | $863,000 | – | 1,000,000 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STEELHEAD PARTNERS LLC | 51,550,000 | $44,471,000 | 3.48% |
CAMDEN ASSET MANAGEMENT L P /CA | 57,100,000 | $49,298,000 | 1.56% |
CANYON CAPITAL ADVISORS LLC | 70,000,000 | $60,020,000 | 1.22% |
ADVENT CAPITAL MANAGEMENT /DE/ | 67,972,000 | $58,675,000 | 1.14% |
SHENKMAN CAPITAL MANAGEMENT INC | 10,300,000 | $8,952,000 | 1.02% |
Ferox Capital Management LP | 3,100,000 | $2,674,000 | 0.92% |
Context Capital Management, LLC | 1,350,000 | $1,169,000 | 0.68% |
DeepCurrents Investment Group LLC | 4,200,000 | $4,600,000 | 0.39% |
SSI INVESTMENT MANAGEMENT LLC | 5,600,000 | $4,835,000 | 0.36% |
WOLVERINE ASSET MANAGEMENT LLC | 29,799,000 | $25,720,000 | 0.34% |